Advent Technologies Holdings, Inc.

Advent reported Q4 2023 revenue of $1.5 million, down from $2 million in the prior-year quarter. R&D expense was $4 million, administrative and selling expense was $6.7 million, and total operating expenses were $10.7 million, down $1 million year over year. Net loss was $25.7 million, or $12.04 per share; adjusted net loss was $22.1 million, or $10.32 per share. Restricted cash was $3.6 million at December 31, 2023, down $0.1 million from September 30. Management did not provide 2024 revenue guidance, saying prior revenue targets are no longer valid and it is not forecasting revenue due to uncertainty; instead it highlighted a cost target below $20 million in 2024 versus $50 million in 2023 and said it expects to update on capital-raising efforts soon.

Vasilis Gregoriou framed Advent as a technology company centered on High-Temperature PEM and the Ion Pair MEA, emphasizing advantages in methanol, biogas, aviation, marine, defense, data centers, and heavy-duty mobility. His tone was confident about the technology and partnerships, but pragmatic about the need to avoid low-margin end-product manufacturing and to focus on licensing, joint development, and MEA manufacturing. He repeatedly said 2024 is a restructuring year and that major adoption inflection points are now expected in 2026 and beyond.

Gregoriou said the company is streamlining operations after closing Boston, Denmark, and Philippines operations, and that the business model shift should reduce both OpEx and future CapEx. He cited a 2024 total cost target below $20 million versus $50 million in 2023, and noted that the Danish subsidiary had production costs above $2,000 per kilowatt versus an expected ~$500 per kilowatt at scale for OEMs using Ion Pair MEA. He also said existing cash balances and projected cash flows are not expected to cover the next 12 months, with additional capital being explored. He described restricted cash of $3.6 million at December 31, 2023 and said the company is managing costs closely while seeking external R&D funds and other financing.

There was no Q&A because no analyst questions were asked. Management therefore used the prepared remarks to address likely investor concerns: revenue visibility remains low, old revenue targets are no longer valid, and the company is prioritizing runway over top-line growth. The main answer to concerns around execution and financing was to keep cutting costs, pursue grants and capital raises, and lean into strategic partners such as Airbus, Hyundai, the US Department of Defense, and potential OEM/data center collaborators.